H.R. 4366 - Consolidated Appropriations Act and Other Extenders Act of 2024 - Issues related to maintaining support for laboratory programs and services for the upcoming fiscal year.
H.R. 2882 - Further Consolidated Appropriations Act of FY2024 - Issues related to the funding of the Department of Health and Human Services and its agencies.
Rules and regulations related to FDA's treatment of certain laboratory developed tests.
Issues related to specific, federally-reimbursed drug testing protocols.
H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program.
Rules, regulations and guidance related to the end of the public health emergency and the treatment of Covid testing, pathology and other related issues.
Issues related to testing for STDs.
Issues related to testing for PFAS.
Issues related to the Cancer Moonshot initiative and addressing ways to combat and prevent cancer.
H.R. 4366 - Consolidated Appropriations and Other Extenders Act of 2024 - Issues related to maintaining support for laboratory programs and services for the upcoming fiscal year.
H.R. 2882 - Further Consolidated Appropriations Act of 2024 - Issues related to funding of programs promulgated by the Department of Health and Human Services and its agencies, including CMS.
Issues related to specific, federally-reimbursed drug testing protocols.
H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program.
Duration: November 1, 2018
to
present
General Issues: Health Issues , Medicare/Medicaid
Spending: about $1,500,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2018: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Office of Science & Technology Policy (OSTP), Centers For Medicare and Medicaid Services (CMS), Health Resources & Services Administration (HRSA), Executive Office of the President (EOP), Vice President of the U.S.
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $80,000. The report was filed on April 14.
Original Filing: 301549130.xml
Lobbying Issues
H.R. 4366 - Consolidated Appropriations Act and Other Extenders Act of 2024 - Issues related to maintaining support for laboratory programs and services for the upcoming fiscal year.
H.R. 2882 - Further Consolidated Appropriations Act of FY2024 - Issues related to the funding of the Department of Health and Human Services and its agencies.
Rules and regulations related to FDA's treatment of certain laboratory developed tests.
Issues related to specific, federally-reimbursed drug testing protocols.
H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program.
Rules, regulations and guidance related to the end of the public health emergency and the treatment of Covid testing, pathology and other related issues.
Issues related to testing for STDs.
Issues related to testing for PFAS.
Issues related to the Cancer Moonshot initiative and addressing ways to combat and prevent cancer.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 4366 - Consolidated Appropriations and Other Extenders Act of 2024 - Issues related to maintaining support for laboratory programs and services for the upcoming fiscal year.
H.R. 2882 - Further Consolidated Appropriations Act of 2024 - Issues related to funding of programs promulgated by the Department of Health and Human Services and its agencies, including CMS.
Issues related to specific, federally-reimbursed drug testing protocols.
H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program.
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $80,000. The report was filed on Dec. 31, 2023.
Original Filing: 301521055.xml
Lobbying Issues
H.R. 6363 - Further Continuing Appropriations and Other Extenders Act of 2024 - Issues related to maintaining support for laboratory programs and services for the upcoming fiscal year.
Rules and regulations related to FDA's treatment of certain laboratory developed tests.
Issues related to specific, federally-reimbursed drug testing protocols.
H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program.
Rules, regulations and guidance related to the end of the public health emergency and the treatment of Covid testing, pathology and other related issues.
Issues related to the Cancer Moonshot initiative and addressing ways to combat and prevent cancer.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6363 - Further Continuing Appropriations and Other Extenders Act of 2024 - Issues related to maintaining support for laboratory programs and services for the upcoming fiscal year.
Issues related to specific, federally-reimbursed drug testing protocols.
H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program.
Rules, regulations and guidance related to the end of the public health emergency and the treatment of Covid testing, pathology and other related issues.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $80,000. The report was filed on Oct. 9, 2023.
Original Filing: 301498581.xml
Lobbying Issues
Rules and regulations related to FDA's treatment of certain laboratory developed tests.
Issues related to specific, federally-reimbursed drug testing protocols.
H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program.
Rules, regulations and guidance related to the end of the public health emergency and the treatment of Covid testing, pathology and other related issues.
Issues related to the Cancer Moonshot initiative and addressing ways to combat and prevent cancer.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to specific, federally-reimbursed drug testing protocols.
H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program.
Rules, regulations and guidance related to the end of the public health emergency and the treatment of Covid testing, pathology and other related issues.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $80,000. The report was filed on July 8, 2023.
Original Filing: 301473867.xml
Lobbying Issues
Issues related to specific, federally-reimbursed drug testing protocols.
H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program.
Rules, regulations and guidance related to the end of the public health emergency and the treatment of Covid testing, pathology and other related issues.
Issues related to the Cancer Moonshot initiative and addressing ways to combat and prevent cancer.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to specific, federally-reimbursed drug testing protocols.
H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program.
Rules, regulations and guidance related to the end of the public health emergency and the treatment of Covid testing, pathology and other related issues.
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $80,000. The report was filed on April 20, 2023.
Original Filing: 301467640.xml
Lobbying Issues
H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program.
Rules, regulations and guidance related to the end of the public health emergency and the treatment of Covid testing, pathology and other related issues.
Issues related to the Cancer Moonshot initiative and addressing ways to combat and prevent cancer.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program.
Rules, regulations and guidance related to the end of the public health emergency and the treatment of Covid testing, pathology and other related issues.
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $80,000. The report was filed on Jan. 17, 2023.
Original Filing: 301429302.xml
Lobbying Issues
H.R. 2617 - The Consolidated Appropriations Act for FY 2023 - Issues related to improving coverage of testing and other lab services in the Medicare program.
S. 4449 - The Saving Access to Laboratory Services Act of 2022 - Issue related to Medicare reimbursement for laboratory services.
Issues related to innovations in cancer screenings.
Issues related to testing for Monkey Pox, Covid-19 and other serious diseases.
PL 117-2 - The American Rescue Act Implementation - Issues related to testing regimes for COVID-19
PL 116-260 - Implementation of previsions related to clinical laboratories,; No Surprises Act and Transparency issues.
Federal policy and programs ensuring an equitable pandemic response and recovery
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 2617 - The Consolidated Appropriations Act for FY 2023 - Issues related to improving coverage of testing and other lab services in the Medicare program.
S. 4449 - The Saving Access to Laboratory Services Act of 2022 - Issue related to Medicare reimbursement for laboratory services.
PL 117-2 - The American Rescue Plan Implementation - Issues related to testing regimes for COVID-19
PL 116-260 - Implementation of previsions related to clinical laboratories and Transparency issues.
Federal policy and programs ensuring an equitable pandemic response and recovery in the testing sector.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $80,000. The report was filed on Oct. 10, 2022.
Original Filing: 301402152.xml
Lobbying Issues
S. 4449 - The Saving Access to Laboratory Services Act of 2022 - Issue related to Medicare reimbursement for laboratory services.
Issues related to innovations in cancer screenings.
Issues related to testing for Monkey Pox, Covid-19 and other serious diseases.
PL 117-2 - The American Rescue Act Implementation - Issues related to testing regimes for COVID-19
PL 116-260 - Implementation of previsions related to clinical laboratories,; No Surprises Act and Transparency issues.
Federal policy and programs ensuring an equitable pandemic response and recovery
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 4449 - The Saving Access to Laboratory Services Act of 2022 - Issue related to Medicare reimbursement for laboratory services.
PL 117-2 - The American Rescue Plan Implementation - Issues related to testing regimes for COVID-19
PL 116-260 - Implementation of previsions related to clinical laboratories and Transparency issues.
Federal policy and programs ensuring an equitable pandemic response and recovery in the testing sector.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $80,000. The report was filed on July 4, 2022.
Original Filing: 301377206.xml
Lobbying Issues
S. 4449 - The Saving Access to Laboratory Services Act of 2022 - Issue related to Medicare reimbursement for laboratory services.
PL 117-2 - The American Rescue Act Implementation - Issues related to testing regimes for COVID-19
PL 116-260 - Implementation of previsions related to clinical laboratories,; No Surprises Act and Transparency issues.
Federal policy and programs ensuring an equitable pandemic response and recovery
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 4449 - The Saving Access to Laboratory Services Act of 2022 - Issue related to Medicare reimbursement for laboratory services.
PL 117-2 - The American Rescue Plan Implementation - Issues related to testing regimes for COVID-19
PL 116-260 - Implementation of previsions related to clinical laboratories and Transparency issues.
Federal policy and programs ensuring an equitable pandemic response and recovery in the testing sector.
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $80,000. The report was filed on April 19, 2022.
Original Filing: 301361860.xml
Lobbying Issues
H.R. 2471 - The Consolidated Appropriations Act of FT 2022 Issues related to protocols and work to include testing in the response to combat the COVD-19 virus and Congressional action to continue to fund such programs.
PL 117-2 - The American Rescue Act Implementation - Issues related to testing regimes for COVID-19
PL 116-260 - Implementation of previsions related to clinical laboratories,; No Surprises Act and Transparency issues.
Federal policy and programs related to k-12 schools testing for COVID-19
Federal policy and programs ensuring an equitable pandemic response and recovery
Issues related laboratory data collection and reimbursement under PAMA.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 2471 - The Consolidated Appropriations Act of FT 2022 Issues related to protocols and work to include testing in the response to combat the COVD-19 virus and Congressional action to continue to fund such programs.
PL 117-2 - The American Rescue Plan Implementation - Issues related to testing regimes for COVID-19
PL 116-260 - Implementation of previsions related to clinical laboratories and Transparency issues.
Federal policy and programs related to k-12 schools testing for COVID-19 through the Medicaid and CHIP programs.
Federal policy and programs ensuring an equitable pandemic response and recovery in the testing sector.
Issues related laboratory data collection and reimbursement under PAMA.
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $60,000. The report was filed on Jan. 11, 2022.
Original Filing: 301321129.xml
Lobbying Issues
Issues related to the Biden Administration's protocols and work to include testing in the response to combat the COVD-19 virus.
PL 117-2 - The American Rescue Act Implementation - Issues related to testing regimes for COVID-19
PL 116-260 - Implementation of previsions related to clinical laboratories,; No Surprises Act and Transparency issues.
Federal policy and programs related to k-12 schools testing for COVID-19
Federal policy and programs ensuring an equitable pandemic response and recovery
Issues related laboratory data collection and reimbursement under PAMA.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Ongoing issues related to the Biden Administration's protocols and work to include testing in the response to combat the COVD-19 virus.
PL 117-2 - The American Rescue Plan Implementation - Issues related to testing regimes for COVID-19
PL 116-260 - Implementation of previsions related to clinical laboratories and Transparency issues.
Federal policy and programs related to k-12 schools testing for COVID-19 through the Medicaid and CHIP programs.
Federal policy and programs ensuring an equitable pandemic response and recovery in the testing sector.
Issues related laboratory data collection and reimbursement under PAMA.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $60,000. The report was filed on Oct. 13, 2021.
Original Filing: 301298469.xml
Lobbying Issues
Issues related to the Biden Administration's protocols and work to include testing in the response to combat the COVD-19 virus.
PL 117-2 - The American Rescue Act Implementation - Issues related to testing regimes for COVID-19
PL 116-260 - Implementation of previsions related to clinical laboratories,; No Surprises Act and Transparency issues.
Federal policy and programs related to k-12 schools testing for COVID-19
Federal policy and programs ensuring an equitable pandemic response and recovery
Issues related laboratory data collection and reimbursement under PAMA.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Ongoing issues related to the Biden Administration's protocols and work to include testing in the response to combat the COVD-19 virus.
PL 117-2 - The American Rescue Plan Implementation - Issues related to testing regimes for COVID-19
PL 116-260 - Implementation of previsions related to clinical laboratories and Transparency issues.
Federal policy and programs related to k-12 schools testing for COVID-19 through the Medicaid and CHIP programs.
Federal policy and programs ensuring an equitable pandemic response and recovery in the testing sector.
Issues related laboratory data collection and reimbursement under PAMA.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $60,000. The report was filed on July 15, 2021.
Original Filing: 301276908.xml
Lobbying Issues
PL 117-2 - The American Rescue Act - Issues related to testing regimes for COVID-19
PL 116-260 - Implementation of previsions related to clinical laboratories,; No Surprises Act and Transparency issues.
Federal policy and programs related to k-12 schools testing for COVID-19
Federal policy and programs ensuring an equitable pandemic response and recovery
Issues related laboratory data collection and reimbursement under PAMA.
Agencies Lobbied
U.S. Senate
Lobbying Issues
PL 117-2 - The American Rescue Plan Implementation - Issues related to testing regimes for COVID-19
PL 116-260 - Implementation of previsions related to clinical laboratories and Transparency issues.
Federal policy and programs related to k-12 schools testing for COVID-19 through the Medicaid and CHIP programs.
Federal policy and programs ensuring an equitable pandemic response and recovery in the testing sector.
Issues related laboratory data collection and reimbursement under PAMA.
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $60,000. The report was filed on April 15, 2021.
Original Filing: 301253894.xml
Lobbying Issues
PL 117-2 - The American Rescue Act - Issues related to testing regimes for COVID-19
PL 116-260 - Implementation of previsions related to clinical laboratories,; No Surprises Act and Transparency issues.
Federal policy and programs related to k-12 schools testing for COVID-19
Federal policy and programs ensuring an equitable pandemic response and recovery
Issues related laboratory data collection and reimbursement under PAMA.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
4th Quarter, 2020
In Q4, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $60,000. The report was filed on Jan. 12, 2021.
Original Filing: 301230052.xml
Lobbying Issues
P.L. 116-260/H.R. 133 - Consolidated Appropriations Act of 2021 - Issues related to the fight against COVID-19 including issues of vaccine distribution, testing policies and procedures and support of the nation's health care system, patients, families and their care providers.
H.R. 8319 - Continuing Appropriation Act 2021 - Ensuring that "health extenders" are addressed.
H.R. 8406 - The HEROES Act (modified) - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19.
Senate HEALS Act - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19.
Issues related to Administration policies on testing for COVID-19 as well as back to work protocols that include testing.
H.R. 6074 - Implementation - Coronavirus Preparedness and Response Supplemental Appropriation Act of 2020- Issues related to lab-focused role and response to fighting COVID-19 pandemic. Issues related to the modification of PAMA statute to respond to the health crisis.
H.R. 6201 - Implementation- Families First Coronavirus Response Act - Issues related to ensuring that the lab-focused capacity and response to fighting the coronavirus are an integral part of the overall federal strategy for keeping the country safe.
H.R. 748 - The CARES Act - Implementation- Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19.
Agencies Lobbied
U.S. Senate
Lobbying Issues
P.L. 116-260/H.R. 133 - Consolidated Appropriations Act of 2021 - Issues related to the fight against COVID-19 including issues of vaccine distribution, testing policies and procedures and support of the nation's health care system, patients, families and their care providers.
H.R. 8319 - Continuing Appropriation Act 2021 - Ensuring that "health extenders" are addressed.
H.R. 8406 - The HEROES Act (modified) - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19.
Senate HEALS Act - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19.
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriation Act of 2020- Implementation - Issues related to lab-focused role and response to fighting COVID-19 pandemic. Issues related to the modification of PAMA statute to respond to the health crisis.
H.R. 6201 - Families First Coronavirus Response Act - Implementation - Issues related to ensuring that the lab-focused capacity and response to fighting the coronavirus are an integral part of the overall federal strategy for keeping the country safe.
H.R. 748 - The CARES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $60,000. The report was filed on Oct. 14, 2020.
Original Filing: 301209774.xml
Lobbying Issues
H.R. 8319 - Continuing Appropriation Act 2021 - Ensuring that "health extenders" are addressed.
H.R. 8406 - The HEROES Act (modified) - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19.
Senate HEALS Act - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19.
Issues related to Administration policies on testing for COVID-19 as well as back to work protocols that include testing.
H.R. 6800 - The HEROES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19.
H.R. 6074 - Implementation - Coronavirus Preparedness and Response Supplemental Appropriation Act of 2020- Issues related to lab-focused role and response to fighting COVID-19 pandemic. Issues related to the modification of PAMA statute to respond to the health crisis.
H.R. 6201 - Implementation- Families First Coronavirus Response Act - Issues related to ensuring that the lab-focused capacity and response to fighting the coronavirus are an integral part of the overall federal strategy for keeping the country safe.
H.R. 748 - The CARES Act - Implementation- Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 8319 - Continuing Appropriation Act 2021 - Ensuring that "health extenders" are addressed.
H.R. 8406 - The HEROES Act (modified) - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19.
Senate HEALS Act - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19.
H.R. 6800 - The HEROES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19 for Medicare and Medicaid beneficiaries.
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriation Act of 2020- Implementation - Issues related to lab-focused role and response to fighting COVID-19 pandemic. Issues related to the modification of PAMA statute to respond to the health crisis.
H.R. 6201 - Families First Coronavirus Response Act - Implementation - Issues related to ensuring that the lab-focused capacity and response to fighting the coronavirus are an integral part of the overall federal strategy for keeping the country safe.
H.R. 748 - The CARES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $60,000. The report was filed on July 4, 2020.
Original Filing: 301185307.xml
Lobbying Issues
Issues related to Administration policies on testing for COVID-19 as well as back to work protocols that include testing.
H.R. 6800 - The HEROES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19.
H.R. 6074 - Implementation - Coronavirus Preparedness and Response Supplemental Appropriation Act of 2020- Issues related to lab-focused role and response to fighting COVID-19 pandemic. Issues related to the modification of PAMA statute to respond to the health crisis.
H.R. 6201 - Implementation- Families First Coronavirus Response Act - Issues related to ensuring that the lab-focused capacity and response to fighting the coronavirus are an integral part of the overall federal strategy for keeping the country safe.
H.R. 748 - The CARES Act - Implementation- Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6800 - The HEROES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19 for Medicare and Medicaid beneficiaries.
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriation Act of 2020- Implementation - Issues related to lab-focused role and response to fighting COVID-19 pandemic. Issues related to the modification of PAMA statute to respond to the health crisis.
H.R. 6201 - Families First Coronavirus Response Act - Implementation - Issues related to ensuring that the lab-focused capacity and response to fighting the coronavirus are an integral part of the overall federal strategy for keeping the country safe.
H.R. 748 - The CARES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19.
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $60,000. The report was filed on April 17, 2020.
Original Filing: 301170391.xml
Lobbying Issues
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriation Act of 2020- Issues related to lab-focused role and response to fighting COVID-19 pandemic. Issues related to the modification of PAMA statute to respond to the health crisis.
H.R. 6201 - Families First Coronavirus Response Act - Issues related to ensuring that the lab-focused capacity and response to fighting the coronavirus are an integral part of the overall federal strategy for keeping the country safe.
H.R. 748 - The CARES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
4th Quarter, 2019
In Q4, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $60,000. The report was filed on Jan. 8, 2020.
Original Filing: 301103848.xml
Lobbying Issues
H.R. 1865 - Further Consolidated Appropriations Act, 2020 - inclusion of policies regarding data collection from laboratories as dictated by the Protecting Access to Medicare Act (PAMA).
H.R. 3584 - The Lab Act - focused on issues related to reform of the Protecting Access to Medicare Act (PAMA) with a focus on ensuring that the data collected to set rates is of the highest integrity.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1865 - Further Consolidated Appropriations Act, 2020 - inclusion of policies regarding data collection from laboratories as dictated by the Protecting Access to Medicare Act (PAMA).
H.R. 3584 - The LAB Act - focused on issues related to reform of the Protecting Access to Medicare Act (PAMA) with a focus on ensuring that the data collected to set rates is of the highest integrity.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $60,000. The report was filed on Oct. 13, 2019.
Original Filing: 301064942.xml
Lobbying Issues
H.R. 3584 - The Lab Act - focused on issues related to reform of the Protecting Access to Medicare Act (PAMA) with a focus on ensuring that the data collected to set rates is of the highest integrity.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 3584 - The LAB Act - focused on issues related to reform of the Protecting Access to Medicare Act (PAMA) with a focus on ensuring that the data collected to set rates is of the highest integrity.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $60,000. The report was filed on July 11, 2019.
Original Filing: 301044448.xml
Lobbying Issues
H.R. 3584 - The Lab Act - focused on issues related to reform of the Protecting Access to Medicare Act (PAMA) with a focus on ensuring that the data collected to set rates is of the highest integrity.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 3584 - The LAB Act - focused on issues related to reform of the Protecting Access to Medicare Act (PAMA) with a focus on ensuring that the data collected to set rates is of the highest integrity.
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $60,000. The report was filed on April 9, 2019.
Original Filing: 301023651.xml
Lobbying Issues
Issues related to reform of the Protecting Access to Medicare Act (PAMA) with a focus on ensuring that the data collected to set rates is of the highest integrity.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
4th Quarter, 2018
In Q4, Nathanson+Hauck lobbied for Quest Diagnostics Incorporated , earning $60,000. The report was filed on Jan. 13, 2019.
Original Filing: 301004045.xml
Lobbying Issues
Issues related to the promulgation of the Protecting Access to Medicare Act with a focus on ensuring the new reimbursement formulas are in line with beneficiary needs, differentiation in lab-performed tests and general practice guidelines.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
4th Quarter, 2018
Nathanson+Hauck filed a lobbying registration on Nov. 14, 2018 to represent Quest Diagnostics Incorporated, effective Nov. 1, 2018.
Original Filing: 301000425.xml
Issue(s) they said they’d lobby about: Issues related to innovation, access and affordability of laboratory-based health care modalities in the United States. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...